Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis

Alzheimer's disease: the amyloid cascade hypothesis

Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · see citing works

Cytokine-mediated regulation of CXCR4 expression in human neutrophils

Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713 · see citing works

Pro-resolving lipid mediators are leads for resolution physiology

Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects

Samuelsson, B. O., Dahlén, S., LINDGREN, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233 · see citing works

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · see citing works

Resolvins

Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · see citing works

Polyunsaturated fatty acids and their metabolites in brain function and disease

Bazinet, R. P., & Layé, S. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3820 · Cited by 1,613 · see citing works

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies

McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · see citing works

Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · see citing works

Tau in Alzheimer Disease and Related Tauopathies

Iqbal, K., Liu, F., Gong, C., & Grundke, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,122 · see citing works

Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta

Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004 · see citing works

Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells

Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000 · see citing works

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease

Lukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 873 · see citing works

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836 · see citing works

Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells

Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 822 · see citing works

Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 811 · see citing works

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802 · see citing works

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., & Bazan, N. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402531101 · Cited by 753 · cited 1× · see citing works

ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial

Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751 · see citing works

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C., Yang, R., Petasis, N. A., & Serhan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907342107 · Cited by 738 · see citing works

Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease

Khan, U. A., Liu, L., Provenzano, F. A., Berman, D. E., Profaci, C. P., Sloan, R., Mayeux, R., Duff, K. E., & Small, S. A. (2014) · Nature Neuroscience · doi:10.1038/nn.3606 · Cited by 561 · see citing works

Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators

Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 556 · see citing works

Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes

Serhan, C. N., Gotlinger, K. H., Hong, S., Lu, Y., Siegelman, J. N., Baer, T. E., Yang, R., Colgan, S. P., & Petasis, N. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1848 · Cited by 457 · see citing works

Brain microglia constitutively express β-2 integrins

Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430 · see citing works

Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue

Colas, R. A., Shinohara, M., Dalli, J., Chiang, N., & Serhan, C. N. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00024.2014 · Cited by 424 · see citing works

Microglial Activation Resulting from CD40-CD40L Interaction After β-Amyloid Stimulation

Tan, J., Town, T., Paris, D., Mori, T., Suo, Z., Crawford, F., Mattson, M. P., Flavell, R. A., & MULLAN, M. J. (1999) · Science · doi:10.1126/science.286.5448.2352 · Cited by 351 · see citing works

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains

Karch, C. M., Jeng, A. T., Nowotny, P., Cady, J., Cruchaga, C., & Goate, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050976 · Cited by 328 · see citing works

PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice

Yamanaka, M., Ishikawa, T., Griep, A., Axt, D., Kummer, M. P., & Heneka, M. T. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1569-12.2012 · Cited by 326 · see citing works

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

Aisen, P. S. S., & Davis, K. L. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1105 · Cited by 325 · see citing works

Resolution of inflammation is altered in Alzheimer's disease

Wang, X., Zhu, M., Hjorth, E., Cortés‐Toro, V., Eyjolfsdottir, H., Graff, C., Nennesmo, I., Palmblad, J., Eriksdotter, M., Sambamurti, K., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.024 · Cited by 301 · see citing works

The novel 13 <i>S</i> ,14 <i>S</i> ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A ₄ hydrolase (LTA ₄ H), and shifts macrophage phenotype

Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-227728 · Cited by 283 · see citing works

TNFα plus IFNγ induce the production of Alzheimer β‐amyloid peptides and decrease the secretion of APPs

Blasko, I., Marx, F., Steiner, E., Hartmann, T., & Grubeck-Loebenstein, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 278 · see citing works

Lipoxin A4 Stable Analogs Are Potent Mimetics That Stimulate Human Monocytes and THP-1 Cells via a G-protein-linked Lipoxin A4 Receptor

Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., & Serhan, C. N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.6972 · Cited by 269 · see citing works

Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia

Pillay, J., Ramakers, B. P., Kamp, V. M., Loi, A. T. L. T., Lam, S. W., Hietbrink, F., Leenen, L. P. H., Tool, A. T. J., Pickkers, P., & Koenderman, L. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209793 · Cited by 256 · see citing works

12/15-Lipoxygenase Is Increased in Alzheimer's Disease

Praticò, D., Zhukareva, V. A., Yao, Y., Uryu, K., Funk, C. D., Lawson, J. A., Trojanowski, J. Q., & Lee, V. M. ‐. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63724-8 · Cited by 248 · see citing works

Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures.

Simone, R. D., Ajmone‐Cat, M. A., Carnevale, D., & Minghetti, L. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-4 · Cited by 248 · see citing works

Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models

Zhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243 · see citing works

Omega-3 Fatty Acids Enhance Phagocytosis of Alzheimer's Disease-Related Amyloid-β 42 by Human Microglia and Decrease Inflammatory Markers

Hjorth, E., Zhu, M., Toro, V. C., Vedin, I., Palmblad, J. E. W., Cederholm, T., Freund‐Levi, Y., Irving, G. F., Wahlund, L., Basun, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130131 · Cited by 228 · see citing works

Cytosolic Phospholipase A2(cPLA2) Immunoreactivity Is Elevated in Alzheimer's Disease Brain

Stephenson, D. T., Lemere, C. A., Selkoe, D. J., & Clemens, J. A. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0005 · Cited by 220 · see citing works

Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease

Astarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218 · see citing works

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

Bo, R. D., Angeretti, N., Lucca, E., Simoni, M. G. D., & Forloni, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11384-9 · Cited by 205 · see citing works

Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.

Cacabelos, R., Alvarez, X. A., Fernández‐Novoa, L., Franco, A., Mangues, R., Pellicer, À., & Nishimura, T. (1994) · PubMed · Cited by 182 · see citing works

5‐Lipoxygenase gene disruption reduces amyloid‐β pathology in a mouse model of Alzheimer's disease

Firuzi, O., Zhuo, J., Chinnici, C. M., Wısnıewskı, T., & Praricò, D. (2007) · The FASEB Journal · doi:10.1096/fj.07-9131.com · Cited by 172 · see citing works

Aspirin-Triggered Lipoxin A4 Stimulates Alternative Activation of Microglia and Reduces Alzheimer Disease–Like Pathology in Mice

Medeiros, R., Kitazawa, M., Passos, G. F., Baglietto-Vargas, D., Cheng, D., Cribbs, D. H., & LaFerla, F. M. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.051 · Cited by 163 · see citing works

The oxidative stress hypothesis in Alzheimer's disease.

Pădurariu, M., Ciobica, A. S., Lefter, R. M., Șerban, I. L., Ștefănescu, C., & Chiriță, R. (2013) · PubMed · Cited by 151 · see citing works

Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway

Liao, Z., Dong, J., Wu, W., Yang, T., Wang, T., Guo, L., Chen, L., Xu, D., & Wen, F. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-110 · Cited by 149 · see citing works

n−3 Fatty acid proportions in plasma and cognitive performance in older adults

Dullemeijer, C., Durga, J., Brouwer, I. A., van de Rest, O., Kok, F. J., Brummer, R.-J. M., van Boxtel, M. P., & Verhoef, P. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1479 · Cited by 148 · see citing works

Increased 5-Lipoxygenase Immunoreactivity in the Hippocampus of Patients With Alzheimer's Disease

Ikonomović, M. D., Abrahamson, E. E., Uz, T., Manev, H., & DeKosky, S. T. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951855 · Cited by 147 · see citing works

PPARγ‐dependent regulation of human macrophages in phagocytosis of apoptotic cells

Majai, G. E., Sarang, Z., Csomós, K., Zahuczky, G., & Fésüs, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200636398 · Cited by 146 · see citing works

Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma

Xu, Z., Liu, X., Berta, T., Park, C., Lü, N., Serhan, C. N., & Ji, R. (2013) · Annals of Neurology · doi:10.1002/ana.23928 · Cited by 141 · see citing works

Agonists for the peroxisome proliferator‐activated receptor‐α and the retinoid X receptor inhibit inflammatory responses of microglia

Xu, J., Storer, P. D., Chavis, J. A., Racke, M. K., & Drew, P. D. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20518 · Cited by 141 · see citing works

Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects

SKINNER, E. R., Watt, C., BESSON, J. A. O., & Best, P. V. (1993) · Brain · doi:10.1093/brain/116.3.717 · Cited by 137 · see citing works

Protein Kinase A Inhibits Leukotriene Synthesis by Phosphorylation of 5-Lipoxygenase on Serine 523

Luo, M., Jones, S. M., Phare, S. M., Coffey, M., Peters-Golden, M. L., & Brock, T. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312568200 · Cited by 135 · see citing works

1α,25-Dihydroxyvitamin D3 and Resolvin D1 Retune the Balance between Amyloid-β Phagocytosis and Inflammation in Alzheimer's Disease Patients

Mizwicki, M. T., Liu, G., Fiala, M., Magpantay, L. I., Sayre, J. W., Siani, A., Mahanian, M., Weitzman, R. E., Hayden, E. Y., Rosenthal, M. J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121735 · Cited by 135 · see citing works

Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases

Togo, T., Akiyama, H., Kondo, H., Ikeda, K., Kato, M., Iseki, E., & Kosaka, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02984-x · Cited by 131 · see citing works

Plasticity of Leukocytic Exudates in Resolving Acute Inflammation Is Regulated by MicroRNA and Proresolving Mediators

Li, Y., Dalli, J., Chiang, N., Baron, R. M., Quintana, C., & Serhan, C. N. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.011 · Cited by 126 · see citing works

Synthesis of Lipoxin A4by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke

Sobrado, M., Pereira, M. P., Ballesteros, I., Hurtado, O., Fernández‐López, D., Pradillo, J. M., Caso, J. R., Vivancos, J., Nombela, F., Serena, J. L., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5529-08.2009 · Cited by 125 · see citing works

Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways

Prieto, P., Cuenca, J., Través, P. G., Fernández‐Velasco, M., Martín‐Sanz, P., & Boscá, L. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.220 · Cited by 123 · see citing works

Arachidonate 5‐Lipoxygenase and Its Activating Protein: Prominent Hippocampal Expression and Role in Somatostatin Signaling

Lammers, C.-H., Schweitzer, P., Facchinetti, P., Arrang, J., Madamba, S. G., Siggins, G. R., & Piomelli, D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66010147.x · Cited by 115 · see citing works

The Vi Capsular Polysaccharide Prevents Complement Receptor 3-Mediated Clearance of <i>Salmonella enterica</i> Serotype Typhi

Wilson, R. P., Winter, S. E., Spees, A. M., Winter, M. G., Nishimori, J. H., Sanchez, J. F., Nuccio, S.-P., Crawford, R. W., Tükel, C., & Bäumler, A. J. (2011) · Infection and Immunity · doi:10.1128/iai.00961-10 · Cited by 113 · see citing works

Hematopoietic Prostaglandin D Synthase and DP1 Receptor Are Selectively Upregulated in Microglia and Astrocytes Within Senile Plaques From Human Patients and in a Mouse Model of Alzheimer Disease

Mohri, I., Kadoyama, K., Kanekiyo, T., Sato, Y., Kagitani‐Shimono, K., Saito, Y., Suzuki, K., Kudo, T., Takeda, M., Urade, Y., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240472.43038.27 · Cited by 85 · see citing works

Protectin DX, a Double Lipoxygenase Product of DHA, Inhibits Both ROS Production in Human Neutrophils and Cyclooxygenase Activities

Liu, M., Boussetta, T., Makni‐Maalej, K., Fay, M., Driss, F., Benna, J. E., Lagarde, M., & Guichardant, M. (2013) · Lipids · doi:10.1007/s11745-013-3863-6 · Cited by 75 · see citing works

Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain

Ohtsuki, T., Matsumoto, M., Hayashi, Y., Yamamoto, K., Kitagawa, K., Ogawa, S., Yamamoto, S., & Kamada, T. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.3.h1249 · Cited by 75 · see citing works

Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury

Luo, C., Li, Q., Chen, X., Zhang, X.-M., Li, L., Li, B., Zhao, Z., & Tao, L. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.037 · Cited by 74 · see citing works

Staurosporine-induced neuronal death: multiple mechanisms and methodological implications

Deshmukh, M., & Johnson, E. M. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400641 · Cited by 70 · see citing works

Neuroprotectin D1 Induces Dephosphorylation of Bcl-xL in a PP2A-dependent Manner during Oxidative Stress and Promotes Retinal Pigment Epithelial Cell Survival

Antony, R., Lukiw, W. J., & Bazan, N. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095232 · Cited by 69 · see citing works

Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date

Balas, L., Guichardant, M., Durand, T., & Lagarde, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.11.006 · Cited by 68 · see citing works

Therapeutic implications of the prostaglandin pathway in Alzheimer's disease

Cudaback, E., Jorstad, N. L., Yang, Y. J., Montine, T. J., & Keene, C. D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.014 · Cited by 66 · see citing works

Dissection of the Hyperadhesive Phenotype of Airway Eosinophils in Asthma

Barthel, S. R., Jarjour, N. N., Mosher, D. F., & Johansson, M. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0027oc · Cited by 57 · see citing works

Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production

Ye, Y., Lin, Y., Perez-Polo, J. R., Uretsky, B. F., Ye, Z., Tieu, B. C., & Birnbaum, Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3515 · Cited by 55 · see citing works

Lovastatin modulation of microglial activation via suppression of functional CD40 expression

Townsend, K. P., Shytle, D., Bai, Y., San, N., Zeng, J., Freeman, M. J., Mori, T., Fernandez, F., Morgan, D., Sanberg, P. R., et al. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20234 · Cited by 52 · see citing works

Staurosporine‐Induced Activation of Caspase‐3 Is Potentiated by Presenilin 1 Familial Alzheimer's Disease Mutations in Human Neuroglioma Cells

Kovacs, D. M., Mancini, R., Henderson, J., Na, S., Schmidt, S. D., Kim, T., & Tanzi, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732278.x · Cited by 52 · see citing works

Non-Steroidal Anti-Inflammatory Drugs and Cognitive Function: Are Prostaglandins at the Heart of Cognitive Impairment in Dementia and Delirium ?

Cunningham, C. M., & Skelly, D. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9312-5 · Cited by 51 · see citing works

β-Amyloid 1-42 Oligomers Impair Function of Human Embryonic Stem Cell-Derived Forebrain Cholinergic Neurons

Wicklund, L., Leão, R. N., Strömberg, A., Mousavi, M. T., Hovatta, O., Nordberg, A. K., & Marutle, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015600 · Cited by 50 · see citing works

12/15-Lipoxygenase Expression Is Increased in Oligodendrocytes and Microglia of Periventricular Leukomalacia

Haynes, R. L., & van Leyen, K. (2013) · Developmental Neuroscience · doi:10.1159/000350230 · Cited by 48 · see citing works

NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival

Calandria, J. M., Asatryan, A., Balaszczuk, V, Knott, E. J., Jun, B. K., Mukherjee, P. K., Belayev, L., & Bazan, N. G. (2015) · Cell Death &amp; Differentiation · doi:10.1038/cdd.2014.233 · Cited by 47 · see citing works

Differential Regulation of Resolution in Inflammation induced by Amyloid-β 42 and Lipopolysaccharides in Human Microglia

Zhu, M., Wang, X., Schultzberg, M., & Hjorth, E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141233 · Cited by 45 · see citing works

Microglial cells and amyloid ? protein (A?) deposition: association with A?40-plaques

Mann, D. M. A., Iwatsubo, T., Fukumoto, H., Ihara, Y., Odaka, A., & Suzuki, N. (1995) · Acta Neuropathologica · doi:10.1007/bf00294808 · Cited by 40 · see citing works

CD40–CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism

Ke, Z., 渡辺, 良., DEGIORGIO, L., Volpe, B. T., & GIBSON, G. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.03.002 · Cited by 32 · see citing works

Ataxin-1 Poly(Q)-induced Proteotoxic Stress and Apoptosis Are Attenuated in Neural Cells by Docosahexaenoic Acid-derived Neuroprotectin D1

Calandria, J. M., Mukherjee, P. K., Vaccari, J. C. D. R., Zhu, M., Petasis, N. A., & Bazan, N. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.287078 · Cited by 30 · see citing works

Breakdown of membrane phospholipids in Alzheimer disease

Farooqui, A. A., Wells, K., & Horrocks, L. A. (1995) · Molecular and Chemical Neuropathology · doi:10.1007/bf02960910 · Cited by 28 · see citing works

NPD1 Induction of Retinal Pigment Epithelial Cell Survival Involves PI3K/Akt Phosphorylation Signaling

Halapin, N., & Bazan, N. G. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0351-8 · Cited by 28 · see citing works

Stimulatory Effects of Peroxisome Proliferator-Activated Receptor- γ on Fc γ Receptor-Mediated Phagocytosis by Alveolar Macrophages

Aronoff, D. M., Serezani, C. H., Carstens, J. K., Marshall, T. M., Gangireddy, S. R., Peters-Golden, M. L., & Reddy, R. C. (2007) · PPAR Research · doi:10.1155/2007/52546 · Cited by 28 · see citing works

Mechanisms Mediating Reduced Responsiveness of Neonatal Neutrophils to Lipoxin A4

Weinberger, B. I., Quizon, C., Vetrano, A. M., Archer, F. E., Laskin, J. D., & Laskin, D. L. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318180e4af · Cited by 27 · see citing works

Differential ability of a thiazolidinedione PPARγ agonist to attenuate cytokine secretion in primary microglia and macrophage‐like cells

Woster, A. P., & Combs, C. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04706.x · Cited by 23 · see citing works

The PPAR‐γ Agonist 15‐Deoxy‐Δ12,14‐Prostaglandin J2 Attenuates Microglial Production of IL‐12 Family Cytokines: Potential Relevance to Alzheimer′s Disease

Xu, J., Barger, S. W., & Drew, P. D. (2008) · PPAR Research · doi:10.1155/2008/349185 · Cited by 22 · see citing works

CD40/CD40L interaction induces Aβ production and increases γ-secretase activity independently of tumor necrosis factor receptor associated factor (TRAF) signaling

Volmar, C., Ait‐Ghezala, G., Frieling, J. S., Weeks, O. I., & MULLAN, M. J. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.04.023 · Cited by 8 · see citing works

Role of neuroinflammation in neurodegeneration development

Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works

Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators

Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · see citing works

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines

Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267 · see citing works

Lipids and Alzheimer’s Disease

Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485 · see citing works

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441 · see citing works

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within

Chiurchiù, V., Leuti, A., & Maccarrone, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00038 · Cited by 427 · see citing works

Anti-inflammatory effects of omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology

Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420 · see citing works

Bioactive lipids, inflammation and chronic diseases

Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 368 · see citing works

Resolution of inflammation: An organizing principle in biology and medicine

Panigrahy, D., Gilligan, M. M., Serhan, C. N., & Kashfi, K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107879 · Cited by 345 · see citing works

Food for thought: how nutrition impacts cognition and emotion

Spencer, S. J., Kőrösi, A., Layé, S., Shukitt‐Hale, B., & Barrientos, R. M. (2017) · npj Science of Food · doi:10.1038/s41538-017-0008-y · Cited by 279 · see citing works

The human microglial HMC3 cell line: where do we stand? A systematic literature review

Russo, C. D., Cappoli, N., Coletta, I., Mezzogori, D., Paciello, F., Pozzoli, G., Navarra, P., & Battaglia, A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1288-0 · Cited by 271 · see citing works

Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions

Chiang, N., Libreros, S., Norris, P. C., de la Rosa, X., & Serhan, C. N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129448 · Cited by 251 · see citing works

Marine omega‐3 (n‐3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health

Ahmmed, M. K., Ahmmed, F., Tian, H. S., Carne, A., & Bekhit, A. E. A. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12510 · Cited by 245 · see citing works

Brain docosahexaenoic acid uptake and metabolism

Lacombe, R. J. S., Chouinard‐Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 205 · see citing works

Fatty acid metabolism in the progression and resolution of CNS disorders

Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167 · see citing works

Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury

Francos-Quijorna, I., Santos-Nogueira, E., Gronert, K., Sullivan, A. B., Kopp, M. A., Brommer, B., David, S., Schwab, J. M., & López‐Vales, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1395-17.2017 · Cited by 163 · see citing works

The anti-inflammatory role of Omega-3 polyunsaturated fatty acids metabolites in pre-clinical models of psychiatric, neurodegenerative, and neurological disorders

Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159 · see citing works

Impact of dietary fats on brain functions

Chianese, R., Coccurello, R., Viggiano, A., Scafuro, M., Fiore, M., Coppola, G., Operto, F. F., Fasano, S., Laye, S., Pierantoni, R., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171017102547 · Cited by 159 · see citing works

N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation

Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 146 · see citing works

Unsaturated Fatty Acids and Their Immunomodulatory Properties

Coniglio, S. J., Shumskaya, M. A., & Vassiliou, E. K. (2023) · Biology · doi:10.3390/biology12020279 · Cited by 145 · see citing works

Resolution of inflammation during multiple sclerosis

Ruiz, F., Vigne, S., & Pot, C. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00765-0 · Cited by 133 · see citing works

Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction

Kooij, G., Troletti, C. D., Leuti, A., Norris, P. C., Riley, I. R., Albanese, M., Ruggieri, S., Libreros, S., van der Pol, S. M. A., Hof, B. V. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.219519 · Cited by 120 · see citing works

Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease

Kantarci, A., Aytan, N., Palaska, I., Stephens, D., Crabtree, L., Benincasa, C., Jenkins, B. G., Carreras, I., & Dedeoglu, A. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.11.005 · Cited by 118 · see citing works

Resolvin D1 Halts Remote Neuroinflammation and Improves Functional Recovery after Focal Brain Damage Via ALX/FPR2 Receptor-Regulated MicroRNAs

Bisicchia, E., Sasso, V., Catanzaro, G., Leuti, A., Besharat, Z. M., Chiacchiarini, M., Molinari, M., Ferretti, E., Viscomi, M. T., & Chiurchiù, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0889-z · Cited by 118 · see citing works

Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics

English, J. T., Norris, P. C., Hodges, R. R., Dartt, D. A., & Serhan, C. N. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.01.004 · Cited by 111 · see citing works

Role of dietary fatty acids in microglial polarization in Alzheimer’s disease

Desale, S. E., & Chinnathambi, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01742-3 · Cited by 110 · see citing works

Dietary omega-3 deficiency exacerbates inflammation and reveals spatial memory deficits in mice exposed to lipopolysaccharide during gestation

Labrousse, V. F., Leyrolle, Q., Amadieu, C., Aubert, A., Séré, A., Coutureau, É., Gregoire, S., Brétillon, L., Pallet, V., Gressèns, P., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.06.004 · Cited by 94 · see citing works

Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review

Whittington, R. A., Planel, E., & Terrando, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01464 · Cited by 89 · see citing works

Interplay Between n‐3 and n‐6 Long‐Chain Polyunsaturated Fatty Acids and the Endocannabinoid System in Brain Protection and Repair

Dyall, S. C. (2017) · Lipids · doi:10.1007/s11745-017-4292-8 · Cited by 88 · see citing works

Omega-3 polyunsaturated fatty acids and brain health: Preclinical evidence for the prevention of neurodegenerative diseases

Kerdiles, O., Layé, S., & Calon, F. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.09.003 · Cited by 85 · see citing works

Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy

Lee, J. Y., Jin, H. K., & Bae, J.-S. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.278 · Cited by 80 · see citing works

Role of Resolvins in the Inflammatory Resolution of Neurological Diseases

Li, C., Wu, X., Liu, S., Shen, D., Zhu, J., & Liu, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00612 · Cited by 80 · see citing works

Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice

Hopperton, K. E., Trépanier, M., Giuliano, V., & Bazinet, R. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0721-5 · Cited by 78 · see citing works

Biomarkers and therapeutic strategies targeting microglia in neurodegenerative diseases: current status and future directions

Noh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 85 · see citing works

Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans

Jónasdóttir, H. S., Brouwers, H., Kwekkeboom, J., van der Linden, H. M. J., Huizinga, T. W. J., Kloppenburg, M., Toes, R. E. M., Giera, M. A., & Ioan‐Facsinay, A. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.01.018 · Cited by 78 · see citing works

Maresin-1 and Inflammatory Disease

Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 78 · see citing works

Maresin 1 Improves Cognitive Decline and Ameliorates Inflammation in a Mouse Model of Alzheimer’s Disease

Yin, P., Wang, X., Wang, S., Wei, Y., Feng, J., & Zhu, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00466 · Cited by 73 · see citing works

n-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging

Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 74 · see citing works

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease

Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 71 · see citing works

Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases

Zhang, H., Tao, Y., & Leng, S. X. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220830102628 · Cited by 71 · see citing works

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Do, K. V., Hjorth, E., Wang, Y., Jun, B., Kautzmann, M.-A. I., Ohshima, M., Eriksdotter, M., Schultzberg, M., & Bazan, N. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01216-5 · Cited by 65 · see citing works

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?

Chiurchiù, V., Tiberi, M., Matteocci, A., Fazio, F., Siffeti, H., Saracini, S., Mercuri, N. B., & Sancesario, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116235 · Cited by 68 · see citing works

Breakdown of the Cerebrovasculature and Blood-Brain Barrier: A Mechanistic Link Between Diabetes Mellitus and Alzheimer’s Disease

Goldwaser, E. L., Acharya, N. K., Sarkar, A., Godsey, G. A., & Nagele, R. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160284 · Cited by 65 · see citing works

Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation

Serhan, C. N., de la Rosa, X., & Jouvene, C. C. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12871 · Cited by 63 · see citing works

The Role of Eicosanoids in Alzheimer’s Disease

Biringer, R. G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142560 · Cited by 63 · see citing works

New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease

Cao, Y., Zhao, L., Chen, Z., & Li, S. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 58 · see citing works

Can inflammation be resolved in Alzheimer’s disease?

Zhu, M., Wang, X., Sun, L., Schultzberg, M., & Hjorth, E. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418791107 · Cited by 61 · see citing works

Receptors for pro‐resolving mediators are increased in Alzheimer's disease brain

Emre, C., Hjorth, E., Bharani, K., Carroll, S., Granholm, A., & Schultzberg, M. (2020) · Brain Pathology · doi:10.1111/bpa.12812 · Cited by 60 · see citing works

Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders

Ponce, J., Ulu, A., Hanson, C., Cameron‐Smith, E., Bertoni, J. M., Wuebker, J., Fisher, A. L., Siu, K., Marmelat, V., Adamec, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.780811 · Cited by 57 · see citing works

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis

Recchiuti, A., Mattoscio, D., & Isopi, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00252 · Cited by 57 · see citing works

Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia

Ebright, B., Assante, I., Poblete, R. A., Wang, S., Duro, M. V., Bennett, D. A., Arvanitakis, Z., Louie, S. G., & Yassine, H. N. (2022) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-022-01084-7 · Cited by 56 · see citing works

The Role of Maresins in Inflammatory Pain: Function of Macrophages in Wound Regeneration

Hwang, S.-M., Chung, G., Kim, Y. H., & Park, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235849 · Cited by 56 · see citing works

Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice

Emre, C., Arroyo-García, L. E., Do, K. V., Jun, B., Ohshima, M., Alcalde, S. G., Cothern, M. L., Maioli, S., Nilsson, P., Hjorth, E., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03169-3 · Cited by 55 · see citing works

Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)

Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 57 · see citing works

Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults – any news?

Cederholm, T. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000350 · Cited by 53 · see citing works

N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease

Lee, J. Y., Han, S. H., Park, M. H., Song, I., Choi, M., Yu, E., Park, C., Kim, H.-J., Kim, S. H., Schuchman, E. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16080-4 · Cited by 53 · see citing works

Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications

Valente, M., Dentoni, M., Bellizzi, F., Kuris, F., & Gigli, G. L. (2022) · Molecules · doi:10.3390/molecules27154836 · Cited by 52 · see citing works

Direct and indirect effects of lipids on microglia function

Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50 · see citing works

Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases

Jaén, R. I., Sánchez‐García, S., Fernández‐Velasco, M., Boscá, L., & Prieto, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658840 · Cited by 50 · see citing works

Pro-resolving lipid mediators: Agents of anti-ageing?

Doyle, R., Sadlier, D. M., & Godson, C. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.002 · Cited by 50 · see citing works

Potential Clinical Applications of Pro-Resolving Lipids Mediators from Docosahexaenoic Acid

Beyer, M. P., Videla, L. A., Farías, C., & Valenzuela, R. (2023) · Nutrients · doi:10.3390/nu15153317 · Cited by 51 · see citing works

Role of metabolic programming in the modulation of microglia phagocytosis by lipids

Nadjar, A. (2018) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2018.07.006 · Cited by 49 · see citing works

Bioactive lipids as new class of microglial modulators: When nutrition meets neuroimunology

Nadjar, A., Leyrolle, Q., Joffre, C., & Layé, S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.004 · Cited by 48 · see citing works

Resolution of Inflammation in Neurodegenerative Diseases: The Role of Resolvins

Chamani, S., Bianconi, V., Tasbandi, A., Pirro, M., Barreto, G. E., Jamialahmadi, T., & Sahebkar, A. (2020) · Mediators of Inflammation · doi:10.1155/2020/3267172 · Cited by 44 · see citing works

Modulation of innate immunity of patients with Alzheimer's disease by omega‐3 fatty acids

Fiala, M., Kooij, G., Wagner, K. M., Hammock, B. D., & Pellegrini, M. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700065r · Cited by 44 · see citing works

Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases

Perucci, L. O., Sugimoto, M. A., Gomes, K. B., Dusse, L. M. S., Teixeira, M. M., & Sousa, L. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1364363 · Cited by 45 · see citing works

Peroxisomal Acyl‐CoA Oxidase Type 1: Anti‐Inflammatory and Anti‐Aging Properties with a Special Emphasis on Studies with LPS and Argan Oil as a Model Transposable to Aging

Vamecq, J., Andreoletti, P., Kebbaj, R. E., Saih, F.-E., Latruffe, N., Kebbaj, M. S. E., Lizard, G., Nasser, B., & Cherkaoui‐Malki, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6986984 · Cited by 42 · see citing works

The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology

Trojan, E., Bryniarska, N., Leśkiewicz, M., Regulska, M., Chamera, K., Szuster-Głuszczak, M., Leopoldo, M., Lacivita, E., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191019170244 · Cited by 42 · see citing works

Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks

Tajbakhsh, A., Read, M. I., Barreto, G. E., Ávila-Rodriguez, M., Hayat, S. M. G., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41 · see citing works

Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation

Serhan, C. N., Bäck, M., Chiurchiù, V., Hersberger, M., Mittendorfer, B., Calder, P. C., Waitzberg, D. L., Stoppe, C., Kłęk, S., Martindale, R. G., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400619r · Cited by 43 · see citing works

Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders

Han, Y., KyeongJin, L., Saha, A., Han, J., Choi, H., Noh, M., Lee, Y., & Lee, M. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.094 · Cited by 40 · see citing works

Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration—A System-Based Preclinical Systematic Review

Liu, W., Yang, Y.-H., Wang, Y.-C., Chang, W., & Wang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311012 · Cited by 39 · see citing works

The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer’s Disease

de Wit, N. M., Mol, K., Rodríguez‐Lorenzo, S., de Vries, H. E., & Kooij, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620348 · Cited by 39 · see citing works

The Relationship of Omega 3 Polyunsaturated Fatty Acids in Red Blood Cell Membranes with Cognitive Function and Brain Structure: A Review Focussed on Alzheimer's Disease

Hooper, C., Barreto, P. D. S., Pahor, M., Weiner, M. W., & Vellas, B. J. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.19 · Cited by 38 · see citing works

A More Comprehensive Approach to the Neuroprotective Potential of Long-Chain Polyunsaturated Fatty Acids in Preterm Infants Is Needed—Should We Consider Maternal Diet and the n-6:n-3 Fatty Acid Ratio?

Klevebro, S., Juul, S. E., & Wood, T. R. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00533 · Cited by 38 · see citing works

Alzheimer’s Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa, K., Fukunaga, H., Tatewaki, Y., Takano, Y., Yamamoto, S., Mutoh, T., & Taki, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165783 · Cited by 38 · see citing works

Lipids and brain inflammation in APOE4-associated dementia

Duro, M. V. V., Ebright, B., & Yassine, H. N. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000801 · Cited by 38 · see citing works

The enzymology of human eicosanoid pathways: the lipoxygenase branches

Biringer, R. G. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05698-8 · Cited by 35 · see citing works

RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome

Hamlett, E. D., Hjorth, E., Ledreux, A., Gilmore, A., Schultzberg, M., & Granholm, A. C. (2020) · Glia · doi:10.1002/glia.23779 · Cited by 34 · see citing works

Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer’s disease

Hopperton, K. E., Trépanier, M., James, N. C. E., Chouinard‐Watkins, R., & Bazinet, R. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.002 · Cited by 34 · see citing works

Lipidomic Analysis of Postmortem Prefrontal Cortex Phospholipids Reveals Changes in Choline Plasmalogen Containing Docosahexaenoic Acid and Stearic Acid Between Cases With and Without Alzheimer’s Disease

Otoki, Y., Kato, S., Nakagawa, K., Harvey, D. J., Jin, L., Dugger, B. N., & Taha, A. Y. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08636-w · Cited by 34 · see citing works

Lipoxins in the Nervous System: Brighter Prospects for Neuroprotection

Zhang, J., Li, Z., Fan, M., & Jin, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.781889 · Cited by 34 · see citing works

Maresin 1 attenuates pro‐inflammatory activation induced by β‐amyloid and stimulates its uptake

Wang, Y., Leppert, A., Tan, S., van der Gaag, B., Li, N., Schultzberg, M., & Hjorth, E. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16098 · Cited by 33 · see citing works

Role of polyunsaturated fatty acids in ischemic stroke – A perspective of specialized pro-resolving mediators

Miao, Z., Schultzberg, M., Wang, X., & Zhao, Y. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.037 · Cited by 33 · see citing works

The role of polyunsaturated fatty acids in the neurobiology of major depressive disorder and suicide risk

Sublette, M. E., Daray, F. M., Ganança, L., & Shaikh, S. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02322-6 · Cited by 34 · see citing works

Resolvin D1 Increases Mucin Secretion in Cultured Rat Conjunctival Goblet Cells via Multiple Signaling Pathways

Lippestad, M., Hodges, R. R., Utheim, T. P., Serhan, C. N., & Dartt, D. A. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-21914 · Cited by 30 · see citing works

Decreased Blood Level of MFSD2a as a Potential Biomarker of Alzheimer’s Disease

Sánchez-Campillo, M., Ruiz-Pastor, M. J., Gázquez, A., Marín-Muñoz, J., Noguera-Perea, F., Ruiz‐Alcaraz, A. J., Manzanares, S., Antúnez, C., & Larqué, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010070 · Cited by 30 · see citing works

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains

Kurano, M., Saito, Y., Uranbileg, B., Saigusa, D., Kano, K., Aoki, J., & Yatomi, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1066578 · Cited by 30 · see citing works

The diverse roles of macrophages in metabolic inflammation and its resolution

Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 32 · see citing works

Prolonged experimental sleep disturbance affects the inflammatory resolution pathways in healthy humans

Engert, L. C., Mullington, J. M., & Haack, M. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.018 · Cited by 29 · see citing works

Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases

Shang, P., Zhang, Y., Ma, D., Hao, Y., Wang, X., Xin, M., Zhang, Y., Zhu, M., & Feng, J. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1691525 · Cited by 29 · see citing works

Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer’s Disease

Fraga, V. G., Magalhaes, C. A., Loures, C. D. M. G., de Souza, L. C., Guimarães, H. C., Zauli, D. A. G., Ferriani, M. D. G. C., Ferreira, C. N., Caramelli, P., Sousa, L. P., et al. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.09.008 · Cited by 28 · see citing works

Resolution of inflammation: Intervention strategies and future applications

Panezai, J., & Dyke, T. E. V. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116089 · Cited by 27 · see citing works

Resolution of inflammation, n − 3 fatty acid supplementation and Alzheimer disease: A narrative review

Fraga, V. G., Ferriani, M. D. G. C., Caramelli, P., Sousa, L. P., & Gomes, K. B. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.005 · Cited by 26 · see citing works

Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer’s Disease

Chávez-Castillo, M., Gotera, M. P., Durán, P., Diaz, M. P., Nava, M., Cano, C., Díaz-Camargo, E. A., Cano, G., Cano, R., Rivera-Porras, D., et al. (2025) · Molecules · doi:10.3390/molecules30153057 · Cited by 26 · see citing works

Fair‐Weather Friends: Evidence of Lipoxin Dysregulation in Neurodegeneration

Kim, C., Livne‐Bar, I., Gronert, K., & Sivak, J. M. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801076 · Cited by 26 · see citing works

Resolvin D1 : A key endogenous inhibitor of neuroinflammation

Roohbakhsh, A., Etemad, L., & Karimi, G. (2022) · BioFactors · doi:10.1002/biof.1891 · Cited by 29 · see citing works

Targeting the Brain with a Neuroprotective Omega-3 Fatty Acid to Enhance Neurogenesis in Hypoxic Condition in Culture

Van, A. L., Sakayori, N., Hachem, M., Belkouch, M., Picq, M., Fourmaux, B., Lagarde, M., Osumi, N., & Bernoud‐Hubac, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1139-0 · Cited by 26 · see citing works

A high fat, sugar, and salt Western diet induces motor‐muscular and sensory dysfunctions and neurodegeneration in mice during aging: Ameliorative action of metformin

Hong, S., Nagayach, A., Lü, Y., Peng, H., Duong, Q.-V., Pham, N. B., Vuong, C. A., & Bazan, N. G. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13726 · Cited by 24 · see citing works

Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study

Möller, I., Rodas, G., Villalón, J. M., Rodas, J. A., Angulo, F., Martínez, N., & Vergés, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04283-4 · Cited by 25 · see citing works

Resolution of inflammation in Alzheimer’s disease

Wang, X. (2014) · Figshare

Maresin 1 attenuates pro‐inflammatory activation induced by β‐amyloid and stimulates its uptake

Wang, Y., Leppert, A., Tan, S., van der Gaag, B., Li, N., Schultzberg, M., & Hjorth, E. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16098 · Cited by 33 · see citing works

P1‐099: ALTERED LIPID MEDIATORS AND RECEPTORS OF RESOLUTION IN THE ENTORHINAL CORTEX OF ALZHEIMER'S DISEASE

Wang, X., Granholm, A., Fitzgerald, J. M., Serhan, C. N., & Schultzberg, M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.335 · Cited by 3 · see citing works

Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-β ₄₂ in Neuron-Microglia Co-Culture Models

Yin, P., Wang, S., Wei, Y., Wang, X., Zhang, J., Yin, X., Feng, J., & Zhu, M. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190682 · Cited by 24 · see citing works

P4‐194: STIMULATE RESOLUTION OF INFLAMMATION AS A STRATEGY FOR ALZHEIMER'S DISEASE

Hjorth, E., Zhu, M., & Schultzberg, M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1711